Dezima Pharma
Naarden
About Dezima Pharma
Dezima Pharma develops protein-based compounds for treatment of cardiovascular disease related to dyslipidemia. The company was founded in 2012 and is based in Naarden, the Netherlands.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 10,001+
- Estimated revenue: $1K – $10K
- Total funding: $18.6M
- Funding stage: M&A
- Last round: Series Unknown (Feb 2013)
- Website: dezimapharma.com
- Phone: +31 35 699 3000
Industries & Categories
Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/dezima-pharma-2215735 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.